DE3665538D1 - Synergistic combination of flupirtin and non-steroidal anti-phlogistics - Google Patents

Synergistic combination of flupirtin and non-steroidal anti-phlogistics

Info

Publication number
DE3665538D1
DE3665538D1 DE8686100537T DE3665538T DE3665538D1 DE 3665538 D1 DE3665538 D1 DE 3665538D1 DE 8686100537 T DE8686100537 T DE 8686100537T DE 3665538 T DE3665538 T DE 3665538T DE 3665538 D1 DE3665538 D1 DE 3665538D1
Authority
DE
Germany
Prior art keywords
flupirtin
phlogistics
steroidal anti
synergistic combination
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8686100537T
Other languages
English (en)
Inventor
Ulrich Dr Tibes
Carl Heinrich Dr Weischer
Helmut Dr Hettche
Hans-Peter Prof Breuel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asta Medica GmbH
Original Assignee
Asta Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Pharma AG filed Critical Asta Pharma AG
Priority to DE8686100537T priority Critical patent/DE3665538D1/de
Application granted granted Critical
Publication of DE3665538D1 publication Critical patent/DE3665538D1/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE8686100537T 1985-01-23 1986-01-17 Synergistic combination of flupirtin and non-steroidal anti-phlogistics Expired DE3665538D1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE8686100537T DE3665538D1 (en) 1985-01-23 1986-01-17 Synergistic combination of flupirtin and non-steroidal anti-phlogistics

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3502005 1985-01-23
DE8686100537T DE3665538D1 (en) 1985-01-23 1986-01-17 Synergistic combination of flupirtin and non-steroidal anti-phlogistics

Publications (1)

Publication Number Publication Date
DE3665538D1 true DE3665538D1 (en) 1989-10-19

Family

ID=6260451

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686100537T Expired DE3665538D1 (en) 1985-01-23 1986-01-17 Synergistic combination of flupirtin and non-steroidal anti-phlogistics

Country Status (15)

Country Link
US (1) US4778799A (de)
EP (1) EP0189788B1 (de)
JP (1) JPH0623103B2 (de)
AT (1) ATE46265T1 (de)
AU (1) AU574557B2 (de)
CA (1) CA1259260A (de)
DD (1) DD244293A5 (de)
DE (1) DE3665538D1 (de)
DK (1) DK30486A (de)
ES (1) ES8705762A1 (de)
FI (1) FI860304L (de)
GR (1) GR860178B (de)
HU (1) HUT39603A (de)
PT (1) PT81885B (de)
ZA (1) ZA86481B (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010063612A1 (de) 2010-12-20 2012-06-21 Awd.Pharma Gmbh & Co. Kg Neue Multikomponentenkristalle aus ([2-Amino-6-(4-fluoro-benzylamino)-pyridin-3-yl]-carbamidsäureethylester und 2-[2-[(2,6-Dichlorphenyl)-amino]-phenyl]-essigsäure
DE102010063609A1 (de) 2010-12-20 2012-06-21 Awd.Pharma Gmbh & Co. Kg Neue Multikomponentenkristalle aus ([2-Amino-6-(4-fluoro-benzylamino)-pyridin-3yl)-carbamidsäureethylester und einer Arylpropionsäure

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5032384A (en) * 1989-01-27 1991-07-16 Block Drug Company, Inc. Compositions and method for the treatment of disease
IN172468B (de) * 1990-07-14 1993-08-14 Asta Medica Ag
ATE160696T1 (de) * 1992-03-11 1997-12-15 Asta Medica Ag Tabletten, granulate und pellets mit hohem gehalt an wirkstoffen für hochkonzentrierte, feste darreichungsformen
DE4319649A1 (de) * 1993-03-18 1994-09-22 Asta Medica Ag Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
JP2920451B2 (ja) * 1993-03-29 1999-07-19 エスエス製薬株式会社 消炎鎮痛貼付剤
KR20020040767A (ko) * 1999-08-03 2002-05-30 아베데 파르마 게엠베하 운트 콤파니 카게 개와 고양이에서 퇴행성 관절 질환으로 인한 통증을경감시키기 위한 플루피르틴의 용도
US20040132815A1 (en) * 2001-04-17 2004-07-08 Yasuhiko Kimoto Preventive/remedial agent for inflammatory disease in oral-cavity mucosa and the like
DE10328260A1 (de) * 2003-06-23 2005-01-27 Schmidt, K.-G., Dr. med. Flupirtine-Präparat
US20050089559A1 (en) * 2003-10-23 2005-04-28 Istvan Szelenyi Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains
DE10359335A1 (de) * 2003-10-23 2005-05-25 Viatris Gmbh & Co. Kg Kombinationen aus Kaliumkanalöffnern und Natriumkanalinhibitoren oder Natriumkanal beeinflussenden Wirkstoffen zur Behandlung von Schmerzzuständen
EP1701725B1 (de) * 2003-12-16 2013-07-31 Relevare Aust. Pty Ltd Zusammensetzungen enthaltend Flupirtine und ein Opioid zur Behandlung neuropathischer Schmerzen
US7960436B2 (en) * 2006-06-05 2011-06-14 Valeant Pharmaceuticals International Substituted arylamino-1,2,3,4-tetrahydro naphthalenes and-2,3-dihydro-1H-indenes as potassium channel modulators
US8993593B2 (en) 2006-08-23 2015-03-31 Valeant Pharmaceuticals International N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulators
SG174095A1 (en) 2006-08-23 2011-09-29 Valeant Pharmaceuticals Int Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators
US8722929B2 (en) 2006-10-10 2014-05-13 Valeant Pharmaceuticals International N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators
CN101578259A (zh) * 2006-11-28 2009-11-11 威朗国际制药公司 作为钾通道调节剂的1,4-二氨基双环瑞替加滨类似物
US20080279930A1 (en) * 2007-05-07 2008-11-13 Bernd Terhaag Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof
US8367684B2 (en) 2007-06-13 2013-02-05 Valeant Pharmaceuticals International Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
US8563566B2 (en) 2007-08-01 2013-10-22 Valeant Pharmaceuticals International Naphthyridine derivatives as potassium channel modulators
US7786146B2 (en) * 2007-08-13 2010-08-31 Valeant Pharmaceuticals International Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators
WO2011102460A1 (ja) * 2010-02-19 2011-08-25 学校法人関西医科大学 胃潰瘍の予防又は治療剤、経口投与薬、及び胃潰瘍の予防又は治療剤の製造方法
US9855286B2 (en) * 2012-05-18 2018-01-02 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-di methyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a salicylic acid component
US9320729B2 (en) 2012-05-18 2016-04-26 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r)-6′-flouro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative
US20130310435A1 (en) 2012-05-18 2013-11-21 Gruenenthal Gmbh Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N, N-dimethyl-4-phenyl-4,9' -dihydro-3'H-spiro[cyclohexane-1,1' -pyrano[3,4,b]indol]-4-amine and Paracetamol or Propacetamol
US20130310385A1 (en) 2012-05-18 2013-11-21 Gruenenthal Gmbh Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine and Antidepressants
TWI886158B (zh) 2019-10-10 2025-06-11 加拿大商再諾製藥公司 選擇性鉀通道調節劑之固態晶型
MX2022005490A (es) 2019-11-08 2022-08-10 Xenon Pharmaceuticals Inc Metodos para el tratamiento de trastornos depresivos.
US11957675B2 (en) 2021-02-09 2024-04-16 Xenon Pharmaceuticals Inc. Methods and uses for treating anhedonia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1211374A (en) * 1982-05-14 1986-09-16 Eszter Cholnoky Pharmaceutical compositions containing more active ingredients
ATE25078T1 (de) * 1982-10-27 1987-02-15 Degussa 2-amino-3-acylamino-6-benzylamino-pyridinderivate mit anti-epileptischer wirkung.
US4447443A (en) * 1982-11-15 1984-05-08 Merck & Co., Inc. Anti-inflammatory/analgesic combination of α-fluoromethylhistidine and a selected non-steroidal anti-inflammatory drug (NSAID)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010063612A1 (de) 2010-12-20 2012-06-21 Awd.Pharma Gmbh & Co. Kg Neue Multikomponentenkristalle aus ([2-Amino-6-(4-fluoro-benzylamino)-pyridin-3-yl]-carbamidsäureethylester und 2-[2-[(2,6-Dichlorphenyl)-amino]-phenyl]-essigsäure
DE102010063609A1 (de) 2010-12-20 2012-06-21 Awd.Pharma Gmbh & Co. Kg Neue Multikomponentenkristalle aus ([2-Amino-6-(4-fluoro-benzylamino)-pyridin-3yl)-carbamidsäureethylester und einer Arylpropionsäure

Also Published As

Publication number Publication date
AU574557B2 (en) 1988-07-07
AU5260486A (en) 1986-07-31
EP0189788B1 (de) 1989-09-13
FI860304A7 (fi) 1986-07-24
DD244293A5 (de) 1987-04-01
DK30486D0 (da) 1986-01-21
PT81885B (pt) 1987-11-30
EP0189788A1 (de) 1986-08-06
ES8705762A1 (es) 1987-05-16
FI860304L (fi) 1986-07-24
JPS61172819A (ja) 1986-08-04
DK30486A (da) 1986-07-24
GR860178B (en) 1986-05-23
ZA86481B (en) 1986-10-29
HUT39603A (en) 1986-10-29
US4778799A (en) 1988-10-18
CA1259260A (en) 1989-09-12
JPH0623103B2 (ja) 1994-03-30
FI860304A0 (fi) 1986-01-22
ES551119A0 (es) 1987-05-16
PT81885A (de) 1986-02-01
ATE46265T1 (de) 1989-09-15

Similar Documents

Publication Publication Date Title
DE3665538D1 (en) Synergistic combination of flupirtin and non-steroidal anti-phlogistics
FI945198L (fi) Farmaseuttiset ja muut annosmuodot
EP0214047A3 (en) Field effect transistor
DE3373275D1 (en) Anti-inflammatory/analgesic combination of alpha-fluoromethylhistidine and a selected non-steroidal anti-inflammatory drug (nsaid)
DE3161290D1 (en) Analgesic and anti-inflammatory agents
IL79505A0 (en) Double injection field effect transistors
TR24607A (tr) Sinerjistik herbisid bilesimleri ve tatbik usulue
EP0228624A3 (en) Field effect transistor
DE3665811D1 (en) Pharmaceutical compositions on the basis of diltiazem and aspirin
GB2222768B (en) Analgesic compounds and compositions
ES8702142A1 (es) Procedimiento para preparar un medicamento a base de 2-amino-3-carboetoxiamino-6-(4-fluoro-bencilamino)-piridina y 4-acetamido-fenol
AU560575B2 (en) Meptazinol and ibuprofen analgesic
ZA865561B (en) Double injection field effect transistors
IL61548A (en) Synergistic analgesic pharmaceutical compositions comprising aspirin and heptaminol
EP0201329A3 (en) A field effect transistor
EP0203516A3 (en) Field effect transistor
GB2081093B (en) A pharmaceutical composition having antiphlogistic antipyretic and analgesic activity
FI950029L (fi) Uusia analgeettisia ja nootrooppisia lääkeaineita
GB2201591B (en) Analgesic antipyretic and anti-inflammatory compositions.
AU2011483A (en) Anti-inflammatory and analgesic phenol derivatives
DE3664258D1 (en) Analgesic and anti-inflammatory medicine made from plants
NZ211052A (en) 1,3-disubstituted-2-oxindoles as analgesic and anti-inflammatory agents
EP0203493A3 (en) Field effect transistor
AU643187B2 (en) Cough-cold mixtures comprising non-steroidal anti-inflammatory drugs
BR6400140U (pt) Embalagem inviolavel aperfeicoada

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ASTA MEDICA AG, 6000 FRANKFURT, DE

8327 Change in the person/name/address of the patent owner

Owner name: ASTA MEDICA AG, O-8020 DRESDEN, DE

8339 Ceased/non-payment of the annual fee